Table 7.

Distribution of the degree to which physicians are being affected by each pricing strategy

No	Description	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
1	Disclosure of actual price of the product	54.0%	30.4%	10.8%	3.2%	1.6%
2	Price discounts technique for the product	38.4%	42.8%	15.2%	1.6%	2.0%
3	Price of the drug and effectiveness of therapy	61.6%	28.4%	7.2%	0.8%	2.0%
4	Price of medication in relation to quality	57.6%	29.6%	8.8%	1.6%	2.4%
5	Price competition among pharmaceutical company	46.0%	32.4%	16.8%	3.6%	1.2%
6	Price for full course therapy	58.4%	29.2%	8.0%	3.2%	1.2%